Research Catalog

Title

The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992.

Author

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy.

Publication

Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993.

Details

Description

iv, 144 p. : ill.; 24 cm.

Subject

• Mifepristone > Government policy > United States
• Pharmaceutical policy > United States
• Medicine > Research > United States
• Import quotas > United States

Note

• Distributed to some depository libraries in microfiche.
• Shipping list no.: 93-0175-P.
• "Serial no. 102-85."

Bibliography (note)

• Includes bibliographical references.

Call Number

READEX Microfiche Y 4.SM 1:102-85

ISBN

0160399661

OCLC

marcive27837766

Author

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy.

Title

The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992.

Imprint

Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993.

Bibliography

Includes bibliographical references.

Gpo Item No.

1031-A

1031-B (MF)

Sudoc No.

Y 4.SM 1:102-85

Research Call Number

READEX Microfiche Y 4.SM 1:102-85